DRW Securities’s Silo Pharma SILO Stock Holding History

DRW Securities’s Portfolio SILO Stock Details SILO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,249	Closed	-$113K	–	1675
2025 Q4	$113K	Buy	+22,249	New	+$164K	﹤0.01%	1053

Other funds holding SILO

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DRW Securities's SILO Position: Q1 2026 in Review

DRW Securities sold out of Silo Pharma (SILO) in Q1 2026, closing a stake of 22,249 shares — an estimated $113K sold.

DRW Securities first reported a position in SILO in Q4 2025 and held it in 1 quarter. The position peaked at $113K in Q4 2025. 14 funds tracked by Wall St. Rank hold SILO as of Q1 2026.

DRW Securities reported no remaining Silo Pharma position as of Q1 2026 after selling out during the quarter.
DRW Securities sold 22,249 Silo Pharma shares in Q1 2026, an estimated $113K.
DRW Securities first reported a position in Silo Pharma in Q4 2025 and held it in 1 quarter.
DRW Securities's Silo Pharma position peaked at $113K in Q4 2025.
14 funds tracked by Wall St. Rank held Silo Pharma as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.